© 2024 Distriphil. Created for free using WordPress and Kubio
Copyright © 2019 DistriPhil | All rights reserved.
© 2024 Distriphil. Created for free using WordPress and Kubio
FOR SUSPECTED ADVERSE REACTIONS please report to the Food and Drug Administration (Philippines) at www.fda.gov.ph and to the DISTRIPHIL Pharmacovigilance Unit through email address [email protected] or you may call or text our 24/7 Pharmacovigilance Hotline at +63-949-884-5386 (Smart). AT THE FIRST SIGN OF AN ADVERSE REACTION, PLEASE SEEK MEDICAL ATTENTION IMMEDIATELY.
Comments are closed